Collaborations & Alliances
Related Searches:
Filter by:
751 - 765 of 1089 results
March 5, 2009
Bristol-Myers Squibb entered a global collaboration with Nissan Chemical Industries, Ltd. and Teijin Pharma Ltd. for the development and commercialization of NTC-801, a selective inhibitor of the acetylcholine-activated potassium ion channel (IKACh), curr
Read More »
February 27, 2009
Cyclogenix has entered into license and research agreements with Wyeth Pharmaceuticals and IMBcom, The University of Queensland’s (UQ) company for commercializing technology from the Institute for Molecular Bioscience (IMB).
Read More »
February 23, 2009
Xencor, Inc. has entered into an antibody optimization collaboration with CSL, Ltd., under which CSL will have access to Xencor’s XmAb technology platform to enhance the ADCC effector function of its therapeutic antibodies.
Read More »
January 29, 2009
Argenta Discovery Ltd. and Zafgen, Inc. have entered a drug discovery collaboration to develop one of Zafgen’s therapeutics programs for obesity.
Read More »
January 19, 2009
Galapagos NV has expanded its anti-infectives alliance with GlaxoSmithKline to include three more discovery targets. Galapagos will receive a payment of $2.7 million from GSK.
In December 2007, the two companies initiated a program to discover an…
Read More »
January 14, 2009
PPD, Inc. has expanded its post-approval drug safety expertise in epidemiology and risk management through a strategic alliance with World Health Information Science Consultants (WHISCON), an epidemiology and drug-safety organization based in Wellesl…
Read More »
January 13, 2009
Bristol-Myers Squibb and ZymoGenetics, Inc. entered a global collaboration for PEG-Interferon lambda, a novel type 3 interferon currently in Phase Ib development for the treatment of Hepatitis C, and its related development program.
Under the term…
Read More »
January 12, 2009
Wyeth and Santaris Pharma have entered into a worldwide strategic alliance to discover, develop and commercialize new medicines based on Santaris' Locked Nucleic Acid (LNA) drug platform, which allows specific targeting and regulation of microRNAs (m…
Read More »
January 9, 2009
XDx, Inc. has signed a collaborative pharmacogenomics agreement with Bristol-Myers Squibb focused on identifying biomarkers for Systemic Lupus Erythematosus (SLE) for clinical diagnostic purposes associated with the development of BMS' rheumatoid art…
Read More »
January 6, 2009
Galapagos NV has successfully achieved a pre-clinical candidate drug in its osteoarthritis alliance with GlaxoSmithKline. Galapagos also reached milestones on other compounds in the alliance, earning milestone payments totaling $10.5 million. Under t…
Read More »
January 5, 2009
PPD, Inc. has purchased Merck’s 130,000-sq.-ft. vaccine testing lab and related equipment in Wayne, PA and hired the 80 Merck employees who operate the facility. PPD will provide assay development and immunogenicity testing services to support…
Read More »
December 23, 2008
GlaxoSmithKline and Archemix Corp. have entered a worldwide strategic alliance to discover, develop and commercialize aptamer therapeutics to treat inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease. Aptamers are synth…
Read More »
December 23, 2008
Forest Laboratories, Inc. and Pierre Fabre Medicament have entered into a definitive collaboration agreement to develop and commercialize F2695 in the U.S. and Canada. F2695 is a selective norepinephrine and serotonin reuptake inhibitor being develop…
Read More »
December 22, 2008
Sanofi-Aventis and Novozymes have signed a development and marketing collaboration for a potential new antibiotic. The drug candidate is an antimicrobial peptide named Plectasin NZ2114 that targets the treatment of severe infections, such as pneumoni…
Read More »
December 22, 2008
AstraZeneca and MAP Pharmaceuticals have formed an exclusive worldwide agreement to develop and commercialize Unit Dose Budesonide (UDB), MAP Pharmaceuticals’ proprietary nebulized formulation of budesonide. UDB is being developed by MAP Pharma…
Read More »
751 - 765 of 1089 results
